Frontline Therapy Setting

Dixie-Lee Esseltine, MD, George Mulligan, PhD
Video Categories: PMO Interview with the Innovator Series: Volume 10

Dixie-Lee Esseltine, MD and George Mulligan, PhD discuss the challenges and gaps in the current standards of care of patients with multiple myeloma, including oral and intravenous treatment options in the frontline therapy setting.
November 10, 2012

PMO Interview with the Innovator Series: Volume 2

The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.

September 20, 2013

The Value of Personalized Medicine

John Hennessy provides a few benefits of personalized medicine as it effects the ability to make better treatment choices earlier rather than later